Blocking GluR2–GAPDH ameliorates experimental autoimmune encephalomyelitis

OBJECTIVE: Multiple sclerosis (MS) is the most common disabling neurological disease of young adults. The pathophysiological mechanism of MS remains largely unknown and no cure is available. Current clinical treatments for MS modulate the immune system, with the rationale that autoimmunity is at the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Dongxu, Lee, Frankie H F, D'Souza, Cheryl, Su, Ping, Zhang, Shouping, Jia, Zhengping, Zhang, Li, Wong, Albert H C, Liu, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402084/
https://www.ncbi.nlm.nih.gov/pubmed/25909084
http://dx.doi.org/10.1002/acn3.182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402084/
https://www.ncbi.nlm.nih.gov/pubmed/25909084
http://dx.doi.org/10.1002/acn3.182

Ejemplares similares